# FewerJobs export - 100 curated jobs Generated: 2026-08-24T11:37:09.991Z Source: https://fewerjobs.com ## Filters applied - **q**: Rasa - **quality_floor**: default - **match_401k_strict**: true - **parental_strict**: true - **non_birth_strict**: true - **pto_strict**: true - **include_older**: false - **apply_url_verified**: false - **page**: 1 - **per_page**: 100 - **sort**: relevance ## Jobs ### (Sr.)RAS/(Assoc.)RAM-RDU-广州 - AstraZeneca - Location: China (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - 401(k) match: listed (not source-backed) - Apply: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/China/XMLNAME--Sr-RAS--Assoc-RAM-RDU-_R-254367-1 - Excerpt: (Sr.)RAS/(Assoc.)RAM-RDU-广州 China posted: Posted Today ### (Sr.)RAS/(Assoc.)RAM-RDU-长沙 - AstraZeneca - Location: China (unspecified) - Salary: Not disclosed - Posted: 2026-06-02 - 401(k) match: listed (not source-backed) - Apply: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/China/XMLNAME--Sr-RAS--Assoc-RAM-RDU-_R-253496 - Excerpt: (Sr.)RAS/(Assoc.)RAM-RDU-长沙 China posted: Posted 10 Days Ago ### (Sr.)RAS/(Assoc.)RAM-RDU-长沙 - AstraZeneca - Location: China (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/China/XMLNAME--Sr-RAS--Assoc-RAM-RDU-_R-251995 - Excerpt: (Sr.)RAS/(Assoc.)RAM-RDU-长沙 China posted: Posted 30+ Days Ago ### Sr. Manager, Risk and Security Intelligence Solutions (RAS) Specialist Seller, KSA, Bahrain and Oman - Visa Inc. - Location: SA - Riyadh, Saudi Arabia (unspecified) - Salary: Not disclosed - Posted: 2026-05-14 - 401(k) match: listed (not source-backed) - Apply: https://visa.wd5.myworkdayjobs.com/visa/job/SA---Riyadh-Saudi-Arabia/Sr-Manager--Risk-and-Security-Intelligence-Solutions--RAS--Specialist-Seller--KSA--Bahrain-and-Oman_REF082072W - Excerpt: Sr. Manager, Risk and Security Intelligence Solutions (RAS) Specialist Seller, KSA, Bahrain and Oman SA - Riyadh, Saudi Arabia posted: Posted 29 Days Ago ### Enterprise Account Executive - USA - Rasa - Location: Remote - USA, United States (remote) - Salary: Not disclosed - Posted: 2026-04-02 - 401(k) match: 4% (not source-backed) - Apply: https://jobs.ashbyhq.com/rasa/83f79edd-ae22-48de-9c1a-352c6ecd302b - Excerpt: Enterprise Account Executive - USA Remote - USA, United States Your turn to start the conversation. Write the future at Rasa. Conversation. It's the thread between our product and our people. The tool that enables us to forge relationships through compassion and expertise. To find the connection between our differences. It keeps us close together across borders and backgrounds and helps us create our shared vision. Rasa means tight-knit. We get to the point and have the courage to ask 'why?'. Because through relentless experimentation, passion, and vision, we're transforming the way people interact with organizations through AI. That's Rasa. That's our message. Join us and add yours. ABOUT THIS ROLE We are looking for a top-performing Enterprise Account Executive to join our team, modeled after the industry's best "technical closers." You will drive revenue growth by identifying, cultivating, and closing complex deals with Fortune 500 and Global 2000 enterprises. In this role, you'll take the time to understand each prospect's unique challenges, map them to Rasa's platform, and clearly show how we can deliver value - both to end users and to decision-makers. You will understand and communicate how Rasa can be used across multiple industries and then manage complex deal cycles. We're a startup, so you'll have to be comfortable rolling up your sleeves and doing whatever is required to support our mission. However, you can expect to: - Build and execute a territory plan to target high-value enterprise accounts. Like our top reps, you are expected to ### Account Executive - USA - Rasa - Location: Remote - USA, United States (remote) - Salary: Not disclosed - Posted: 2026-05-27 - 401(k) match: 4% (not source-backed) - Apply: https://jobs.ashbyhq.com/rasa/c82fedc7-8d48-4a0f-a92d-2673e078b2b8 - Excerpt: Account Executive - USA Remote - USA, United States Your turn to start the conversation. Write the future at Rasa. Conversation. It's the thread between our product and our people. The tool that enables us to forge relationships through compassion and expertise. To find the connection between our differences. It keeps us close together across borders and backgrounds and helps us create our shared vision. Rasa means tight-knit. We get to the point and have the courage to ask 'why?'. Because through relentless experimentation, passion, and vision, we're transforming the way people interact with organizations through AI. That's Rasa. That's our message. Join us and add yours. ABOUT THIS ROLE We are looking for a top-performing Account Executive to join our team, modeled after the industry's best "technical closers." You will drive revenue growth by identifying, cultivating, and closing complex deals with Fortune 500 and Global 2000 enterprises. In this role, you'll take the time to understand each prospect's unique challenges, map them to Rasa's platform, and clearly show how we can deliver value - both to end users and to decision-makers. We are open to consider if you have been a top performer Mid-market / Corporate AE who is looking to level-up into Enterprise selling. You will understand and communicate how Rasa can be used across multiple industries and then manage complex deal cycles. We're a startup, so you'll have to be comfortable rolling up your sleeves and doing whatever is required to support our mission. However, you can ### Senior RAS Training Specialist - Medtronic - Location: Riyadh, Riyadh, Saudi Arabia (unspecified) - Salary: Not disclosed - Posted: 2026-06-03 - Parental leave: 24 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://medtronic.wd1.myworkdayjobs.com/medtroniccareers/job/Riyadh-Riyadh-Saudi-Arabia/Senior-Training-Specialist_R64441-1 - Excerpt: Senior RAS Training Specialist Riyadh, Riyadh, Saudi Arabia posted: Posted 9 Days Ago ### Staff Engineer for RAS - SiFive - Location: Bengaluru, Karnataka, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-10 - 401(k) match: listed (not source-backed) - Apply: https://sifive.wd1.myworkdayjobs.com/sifivecareers/job/Bengaluru-Karnataka-India/Staff-Engineer-for-RAS_R-101051-1 - Excerpt: Staff Engineer for RAS Bengaluru, Karnataka, India posted: ### Senior Server RAS Engineer - NVIDIA Corporation - Location: India, Bengaluru (unspecified) - Salary: Not disclosed - Posted: 2026-05-13 - 401(k) match: listed (not source-backed) - Apply: https://nvidia.wd5.myworkdayjobs.com/NVIDIAExternalCareerSite/job/India-Bengaluru/Senior-Server-RAS-Engineer_JR2007336 - Excerpt: Senior Server RAS Engineer India, Bengaluru posted: Posted 30 Days Ago ### Senior RAS Training Specialist - Medtronic - Location: 5 Locations (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - Parental leave: 24 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://medtronic.wd1.myworkdayjobs.com/medtroniccareers/job/Riyadh-Riyadh-Saudi-Arabia/Senior-RAS-Training-Specialist_R64478 - Excerpt: Senior RAS Training Specialist 5 Locations posted: Posted 30+ Days Ago ### Executive Director, GCP QA (Good Clinical Practice, Quality Assurance) - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $265K-$331K - Posted: 2026-05-05 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7515216003 - Excerpt: Executive Director, GCP QA (Good Clinical Practice, Quality Assurance) Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Executive Director of GCP QA is a senior leadership role responsible for setting and executing the global GCP quality strategy across clinical development programs. This position ensures compliance with regulatory requirements, industry standards, and company policies governing clinical trials. The role provides strategic oversight of GCP QA activities, including leadership of a high-performing QA team, governance of contract research organizations, and advancement of continuous improvement initiatives to uphold the highest standards of quality and patient safety. Serving as the GCP QA lead for late-stage clinical programs, this individual is accountable for GCP, GLP, and Pharmacovigilance/Safety oversight across multiple RevMed studies and represents QA in cross-functional and executive forums. The Executive Director will serve as a key advisor to senior leadership on clinical quality risk and regulatory readiness, helping to shape development strategy and enable successful regulatory outcomes. ### Salesforce Developer, GTM Systems - Cresta - Location: India (Remote) (remote) - Salary: Not disclosed - Posted: 2025-11-17 - Apply: https://job-boards.greenhouse.io/cresta/jobs/4990743008 - Excerpt: Salesforce Developer, GTM Systems India (Remote) Cresta unlocks the true potential of the customer experience, turning every conversation into a competitive advantage. Cresta's unified AI platform combines conversational AI agents, real-time human agent augmentation, and comprehensive conversation intelligence to drive revenue and efficiency gains across every channel. The world's leading companies, including United Airlines, Cox Communications, and Marriott, use Cresta to power world-class customer experiences every day. Born from the Stanford AI Lab, Cresta has raised more than $270 million from the world's leading investors, including a16z, Greylock, and Sequoia. Cresta's leadership includes some of the leading minds in AI today. Our CEO, Ping Wu , founded and led Google's Contact Center AI and Vertex AI platforms before joining Cresta to build the future of AI-driven customer experiences. Over the next few years, AI is going to redefine how people all over the world interact with businesses every day. Come build that future at Cresta. About the role: We're looking for a Salesforce Developer to join our Revenue Technology team in Bangalore. You'll work alongside our Salesforce Architect and GTM Operations to build automations, integrations, and data workflows that power Cresta's revenue engine. This is a remote role, to work EST hours only (7 PM - 4 AM IST) from a remote location in Bangalore, India. Responsibilities: - Build and optimize Salesforce Flows, Apex triggers, and integrations - Support CPQ, quote approval, and lead routing automation - Integrate tools like Clay, Exa, Zapier, Slack, and Gong with Salesforce - Collaborate ### Pega Developer (SSA) - Accenture Federal Services - Location: Washington, DC (unspecified) - Salary: $79K-$160K - Posted: 2026-04-10 - Apply: https://boards.greenhouse.io/accenturefederalservices/jobs/4672263006?gh_jid=4672263006 - Excerpt: Pega Developer (SSA) Washington, DC At Accenture Federal Services, nothing matters more than helping the US federal government make the nation stronger and safer and life better for people. Our 13,000+ people are united in a shared purpose to pursue the limitless potential of technology and ingenuity for clients across defense, national security, public safety, civilian, and military health organizations. Join Accenture Federal Services, a technology company within global Accenture. Recognized as a Glassdoor Top 100 Best Place to Work, we offer a collaborative and caring community where you feel like you belong and are empowered to grow, learn and thrive through hands-on experience, certifications, industry training and more. Join us to drive positive, lasting change that moves missions and the government forward! The work The Pega Senior System Architect (SSA) is responsible for designing, building, and configuring Pega applications that meet complex business process and application requirements. In this role, you will leverage deep Pega Platform expertise to streamline business processes, enhance operational efficiency, and deliver high‑quality technical solutions. You will collaborate closely with business stakeholders, solution architects, and DevOps teams to ensure seamless integration, deployment, and continuous improvement of Pega applications. A strong background in Pega development-supported by required Pega certification-and familiarity with DevOps tools and practices will be key to success. Your ability to interpret business needs, transform them into scalable technical designs, and support the full development lifecycle will play a critical role in driving project outcomes. Key responsibilities - Design, build, and configure Pega Platform ### Sr. Software Engineer - ROR (Ruby on Rails)(5-8Years)- 11508 - Coupa - Location: Pune, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-10 - Apply: https://jobs.lever.co/coupa/7c4eb8b2-f844-42cf-a1a9-540b10655838 - Excerpt: Sr. Software Engineer - ROR (Ruby on Rails)(5-8Years)- 11508 Pune, India Coupa makes margins multiply through its community-generated AI and industry-leading total spend management platform for businesses large and small. Coupa AI is informed by trillions of dollars of direct and indirect spend data across a global network of 10M+ buyers and suppliers. We empower you with the ability to predict, prescribe, and automate smarter, more profitable business decisions to improve operating margins. Why join Coupa? 🔹 Pioneering Technology: At Coupa, we're at the forefront of innovation, leveraging the latest technology to empower our customers with greater efficiency and visibility in their spend. 🔹 Collaborative Culture: We value collaboration and teamwork, and our culture is driven by transparency, openness, and a shared commitment to excellence. 🔹 Global Impact: Join a company where your work has a global, measurable impact on our clients, the business, and each other. Learn more on Life at Coupa blog and hear from our employees about their experiences working at Coupa. The Impact of a Sr. Software Engineer at Coupa: At a technical level your development team will offer application and infrastructure support for customer environments. You'll have the opportunity to collaborate across software products with engineers all over the company and globe to plan and deploy product releases. What You'll Do What You Will Bring to Coupa ### [KSA] Data & AI – Senior Consultant / Associate Manager - Spring in Africa - Location: Riyadh, , Saudi Arabia (unspecified) - Salary: Not disclosed - Posted: 2026-06-10 - Apply: https://jobs.smartrecruiters.com/Sia/744000127134832--ksa-data-ai-senior-consultant-associate-manager - Excerpt: [KSA] Data & AI – Senior Consultant / Associate Manager Riyadh, , Saudi Arabia Company Description: Sia is a specialist Management Consulting firm born in Paris, France in 1999 and has grown into a global firm with over 3,000 employees and annual revenue exceeding $500m. Our culture is strongly oriented towards high-quality expertise and delivering excellent results and outcomes for our clients, which include a wide range of multinational companies. Testament to its success, Sia has shown double-digit growth every year since inception. Sia is a pioneer of Consulting 4.0, putting us at the forefront of the technology revolution, deploying augmented Consultants capable of leveraging emerging digital technology to enhance and improve their cognitive reasoning, analysis and planning. Supported by Augmented & Artificial Intelligence, Automation and Data Science we empower our clients to make the right decisions at the right time for the right reasons. With our consultants representing 41 different nationalities, we are a highly diverse team spread across 48 offices in 19 countries. However, using innovative technologies such as our own in-house apps, social networks, and digital tools, we provide a truly integrated global service. Sia is an equal opportunities employer, committed to diversity, inclusion, and employee well-being. Our diversity and inclusion networks (local and global) contribute to a pipeline of initiatives to enhance employee quality of life and foster a caring environment to work in. Employees are encouraged to contribute to these initiatives and drive positive change in the organisation across 5 pillars: Women@Sia, Multi-Ethnic, Well-being, and ### Senior Manager, Medical Science Liaison, Japan - Revolution Medicines - Location: Remote (Japan) (remote) - Salary: Not disclosed - Posted: 2026-06-09 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7767672003 - Excerpt: Senior Manager, Medical Science Liaison, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Medical Science Liaison (MSL). Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Reporting to JP Regional Medical Science Liaison (JPR MSL), MSLs are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence ### Associate Director, Medical Lead GI, Japan - Revolution Medicines - Location: Remote (Japan) (remote) - Salary: Not disclosed - Posted: 2026-06-09 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7767663003 - Excerpt: Associate Director, Medical Lead GI, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Medical Lead (ML) for Gastrointestinal and Pancreatic cancers (GI). This role will include to develop and execute strategic medical plan including evidence generation, publication, congress activities, and so on, engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and organize medical education, advisory boards, and medical activities in congresses. Reporting to the Head of Japan Medical Affairs, ML is an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. ML will serve as a key strategic person between Revolution Medicines and healthcare professionals in collaboration with MSL team. Within assigned geographic territory, ML will be ### Senior Manager, Regulatory Affairs - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695449003 - Excerpt: Senior Manager, Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager of Regulatory Affairs will provide project teams with regulatory advice, manage and coordinate various Regulatory Affairs activities within and between departments, and obtain and maintain National Health Authority approvals for investigational products. The position may also undertake regulatory intelligence and research supporting company decision-making. - Manage planning, preparation, coordination, and submission of regulatory documents to global National Health Authorities. Such submissions may include Clinical, Preclinical, or CMC content. - Correspond and collaborate with RevMed colleagues and departments to achieve alignment. - Function as a Regulatory Affairs subject matter expert member of cross-functional teams, including study teams and submission teams. - Perform regulatory research to inform business strategy. Assess and communicate risks. - Assure that there are no significant interruptions to the business due to regulatory compliance issues. - Collaborates across the organization at all levels, across functional groups, and with ### Associate Director, Business Operations - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7751588003 - Excerpt: Associate Director, Business Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Business Operations is an internal project manager with a consultant mindset and hands-on approach. This is an execution-focused role that strengthens the business capabilities in the Development & Clinical Sciences (DCS) organization. This role partners closely with the Development Leadership Team and the Program Leads to design and implement capabilities building projects that enable growth and evolve our ways of working. The role is ideal for a Associate Director -level professional who thrives on execution, can drive several projects in parallel, can navigate a matrix environment, and brings strong project leadership, communication and change management experience. Responsibilities: - Enablement Programs & Tools - Design and deploy practical solutions (e.g., templates, toolkits, playbooks, workflows) that enable DCS teams in their day-to-day work. - Ensure solutions are practical, scalable, and embedded into existing processes. - Partner with subject-matter experts to translate complex ### Senior Counsel, Pharmaceutical Development and Manufacturing - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$282K - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7613277003 - Excerpt: Senior Counsel, Pharmaceutical Development and Manufacturing Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: RevMed is seeking an experienced attorney to support our global manufacturing, supply chain, and technical operations activities. This role will lead the drafting, negotiation, and management of complex agreements with contract development and manufacturing organizations (CDMOs), raw material suppliers, and other third-party vendors critical to drug development and commercialization. The ideal candidate has deep experience in biotech or pharmaceutical contracting, a strong understanding of GMP and regulatory considerations, and the ability to partner effectively with business, technical, and quality teams. A successful candidate will bring proven experience working at a publicly traded life sciences organization, with demonstrated success in driving legal cross-functional strategy. Your Contributions (include, But Are Not Limited To) - Draft, review, and negotiate a wide range of manufacturing-related agreements, including: - CDMO master services agreements and work orders - Manufacturing and supply agreements - Quality agreements (in coordination ### Senior Director, Medical Affairs, Italy - Revolution Medicines - Location: Remote (Italy) (remote) - Salary: Not disclosed - Posted: 2026-04-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7717894003 - Excerpt: Senior Director, Medical Affairs, Italy Remote (Italy) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, General Manager, Italy the Senior Director, Medical Affairs, Italy is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the Italian Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that Italian medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Italian medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as the Medical Affairs lead for Italy, accountable for local medical strategy, execution, and impact ### Senior Delivery Consultant - Connect and Lex, Amazon Connect Center of Delivery Excellence - Amazon - Location: Seattle, Washington, USA (unspecified) - Salary: $154K-$208K - Posted: 2026-05-15 - Parental leave: 6 weeks (not source-backed) - Non-birth-parent leave: 6 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Fertility benefits: yes (not source-backed) - Adoption assistance: yes (not source-backed) - Mental health support: yes (not source-backed) - Childcare support: yes (not source-backed) - Apply: https://www.amazon.jobs/en/jobs/10420828/senior-delivery-consultant-connect-and-lex-amazon-connect-center-of-delivery-excellence - Excerpt: Senior Delivery Consultant - Connect and Lex, Amazon Connect Center of Delivery Excellence Seattle, Washington, USA The Amazon Web Services Professional Services (ProServe) team is seeking a skilled Delivery Consultant to join our team at Amazon Web Services (AWS). In this role, you'll work closely with customers to design, implement, and manage AWS solutions that meet their technical requirements and business objectives. You'll be a key player in driving customer success through their cloud journey, providing technical expertise and best practices throughout the project lifecycle. Possessing a deep understanding of AWS products and services, as a Delivery Consultant you will be proficient in architecting complex, scalable, and secure solutions tailored to meet the specific needs of each customer. You'll work closely with stakeholders to gather requirements, assess current infrastructure, and propose effective migration strategies to AWS. As trusted advisors to our customers, providing guidance on industry trends, emerging technologies, and innovative solutions, you will be responsible for leading the implementation process, ensuring adherence to best practices, optimizing performance, and managing risks throughout the project. The AWS Professional Services organization is a global team of experts that help customers realize their desired business outcomes when using the AWS Cloud. We work together with customer teams and the AWS Partner Network (APN) to execute enterprise cloud computing initiatives. Our team provides assistance through a collection of offerings which help customers achieve specific outcomes related to enterprise cloud adoption. We also deliver focused guidance through our global specialty practices, which cover a variety ### Research Associate II, Proteomics - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $91K-$110K - Posted: 2026-05-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7750162003 - Excerpt: Research Associate II, Proteomics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and detail-oriented individual to support mass spectrometry-based proteomics workflows. This is an excellent opportunity for an early-career scientist to gain hands-on experience in proteomics within a drug discovery environment. This role will focus on executing established laboratory workflows, maintaining high-quality data standards, and supporting the development of new capabilities within the team. Training will be provided for specialized techniques and instrumentation. In this role, success will come from consistently executing workflows with accuracy, maintaining well-documented experiments, and building technical proficiency over time. As a key member of the Proteomics group within our dynamic Chemical Biology team, you will: - Perform sample preparation for bottom-up proteomics workflows using established protocols with high attention to detail and consistency. - Execute and help improve automated proteomics workflows. - Support routine instrument operation, maintenance and quality control of LC and MS/MS ### Associate Director, Global Commercialization Systems Enablement - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $186K-$233K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695502003 - Excerpt: Associate Director, Global Commercialization Systems Enablement Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Global Commercialization Systems Enablement is responsible for coordinating and enabling Commercial and Medical Affairs global systems work across markets outside the United States. This role ensures that regional needs are clearly understood, refined, and effectively integrated into established global processes, including launch orchestration, compliance frameworks, software development lifecycle practices, and prioritization governance. For new market launches outside of the United States, this individual will lead the associated Commercial and Medical business systems workstreams, ensuring coordinated planning, readiness, and execution across regional IT teams, global Commercial and Medical solution teams, and enterprise technology teams. The Associate Director adds value by clarifying requirements, identifying cross market commonalities, and reducing discovery work for global delivery teams such as Omnichannel Solutions, Data Solutions, Medical Affairs Solutions, and Field Solutions. The role supports seamless pull through of work into global intake and execution models, helping ### Principal Scientist, Cancer Pharmacology, Translational Research - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $190K-$238K - Posted: 2026-05-21 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7746574003 - Excerpt: Principal Scientist, Cancer Pharmacology, Translational Research Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Principal Scientist in the Cancer Pharmacology team within the Translational Research group, in the Biomedical Discovery Research Department, you will: - Provide scientific and strategic leadership for RAS(ON) inhibitor programs by translating mechanistic insights in RAS biology into impactful pharmacology strategies and translational study plans. - Lead, mentor, and develop a high-performing group of in vivo scientists, fostering scientific excellence, innovation, and cross-functional collaboration. - Drive the design, execution, and interpretation of in vivo efficacy and PK/PD studies conducted internally and through external partners to advance oncology discovery and development programs. - Partner closely with the cross-functional quantitative modeling group to provide biological insight, translational context, and critical evaluation supporting PK/PD modeling efforts. - Influence portfolio progression through generation of high-impact data packages and contributions to regulatory submissions. - Serve as the in vivo pharmacology expert on cross-functional project ### Senior Research Associate, Proteomics - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $106K-$126K - Posted: 2026-05-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7750316003 - Excerpt: Senior Research Associate, Proteomics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and detail-oriented individual to support and advance mass spectrometry-based proteomics workflows. This role is well-suited for a scientist with prior industry experience who is excited to apply and expand their expertise in proteomics within a drug discovery environment. This position will involve executing and optimizing laboratory workflows, maintaining high-quality data standards, and contributing to the development of new capabilities within the team. The ideal candidate will demonstrate strong technical proficiency, attention to detail, and the ability to work both independently and collaboratively. In this role, success will come from consistently delivering high-quality, reproducible data, maintaining well-documented experiments, and proactively identifying opportunities to improve workflows and efficiency. As a key member of the Proteomics group within our dynamic Chemical Biology team, you will: - Perform sample preparation for bottom-up proteomics workflows with high attention to detail and reproducibility. ### Early Career Software Engineer – Applied AI - Wonderschool - Location: San Francisco (unspecified) - Salary: $100K-$120K - Posted: 2025-02-10 - Apply: https://job-boards.greenhouse.io/wonderschool/jobs/6359139003 - Excerpt: Early Career Software Engineer – Applied AI San Francisco About Wonderschool Wonderschool is harnessing the power of technology to provide comprehensive support to childcare providers operating out of their homes as well as in the government and non-profit sectors. Our products enable childcare providers to create high-quality environments and meet the demands of their business, while also helping parents in need of childcare solutions through the creation of an accessible marketplace. We are seeking a highly skilled and motivated Early Career Software Engineer to join our team. As the Early Career Software Engineer, you will play a crucial role in leading our software development initiatives, working with a talented team to create innovative solutions. Your expertise in delivery of high-quality software will be essential in driving the development of our cutting-edge applications. Role Overview We are seeking an Early Career Software Engineer with an interest in applied AI to join our growing team. This is a unique opportunity to work in a fast-paced, purpose-driven environment where you can apply your technical skills to create meaningful impact in the childcare ecosystem. You'll collaborate with cross-functional teams to build scalable, AI-driven solutions that empower childcare providers and improve parent experiences. This position is on site in our San Francisco office, Tuesday, Wednesday, and Thursday to allow for collaboration. Key Responsibilities - Design, develop, and maintain robust software solutions with a focus on integrating AI capabilities. - Collaborate with product managers, designers, and engineers to define requirements and implement innovative features. - Design ### Senior Director, Payor and Health Systems Liaison, West - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $264K-$290K - Posted: 2026-05-01 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7648509003 - Excerpt: Senior Director, Payor and Health Systems Liaison, West Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Payor and Health Systems Liaison will own and shape the scientific payer/access strategy for the US region. They will develop and cultivate relationships with key decision-makers and other influencers in managed care organizations, government programs, employers, hospital systems and product distribution companies, to support appropriate patient access and evidence-based utilization for Revolution Medicine's products. A key aspect of the Payor and Health Systems Liaison responsibilities is to keep payers and other key external constituents or influencers abreast of new product launches, line extensions and Medical Affairs research. The Payor and Health Systems Liaison leads high‑impact clinical, scientific, and population health engagement with external access stakeholders, including Payers, Group Purchasing Organizations (GPOs), Community Aggregators, and Integrated Delivery Networks (IDNs), while ensuring strong integration between Medical Affairs, HEOR, and Market Access strategy. Responsibilities ### Senior Director, Payor and Health Systems Liaison, East - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $264K-$290K - Posted: 2026-05-01 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7711614003 - Excerpt: Senior Director, Payor and Health Systems Liaison, East Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Payor and Health Systems Liaison will own and shape the scientific payer/access strategy for the US region. They will develop and cultivate relationships with key decision-makers and other influencers in managed care organizations, government programs, employers, hospital systems and product distribution companies, to support appropriate patient access and evidence-based utilization for Revolution Medicine's products. A key aspect of the Payor and Health Systems Liaison responsibilities is to keep payers and other key external constituents or influencers abreast of new product launches, line extensions and Medical Affairs research. The Payor and Health Systems Liaison leads high‑impact clinical, scientific, and population health engagement with external access stakeholders, including Payers, Group Purchasing Organizations (GPOs), Community Aggregators, and Integrated Delivery Networks (IDNs), while ensuring strong integration between Medical Affairs, HEOR, and Market Access strategy. Responsibilities ### Senior Manager, Business Analysis and Project Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-04-14 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695694003 - Excerpt: Senior Manager, Business Analysis and Project Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Business Analysis & Project Management is a strategic leadership role within the Information Sciences organization, responsible for driving enterprise technology initiatives that support pharmaceutical research, development, manufacturing, quality, and commercial operations. This role requires creation of business and Sciences requirements leading to delivery of complex, cross-functional projects while maintaining compliance with regulatory and validation requirements. The role partners closely with business and IS leadership to translate business strategies into scalable, compliant technology solutions, while ensuring projects are delivered on time, within scope, and within budget. Key Responsibilities: Strategic Leadership & Governance - Develop and execute the Business Analysis and Project Management strategy aligned with enterprise IS and business objectives. - Establish and enforce standardized methodologies, templates, tools, and best practices (Agile, Waterfall, Hybrid). - Provide portfolio-level oversight, prioritization, and delivery governance for IS initiatives. - Serve as ### Associate Director, HEOR, Japan - Revolution Medicines - Location: Remote (Japan) (remote) - Salary: Not disclosed - Posted: 2026-06-09 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7767687003 - Excerpt: Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and ### Associate Director, Global Regulatory Affairs Project Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695508003 - Excerpt: Associate Director, Global Regulatory Affairs Project Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Global Regulatory Affairs Project Management is an integral part of the global Regulatory Affairs organization and is responsible for translating global regulatory strategies into actionable execution plans. This role applies advanced project management expertise and operational leadership to guide cross-functional teams, supporting planned and ongoing drug marketing applications across RevMed programs. The role partners closely with Global Regulatory Science and Global Filing and Registration and contributes to the broader Global Regulatory Affairs function at RevMed. This position reports to the Senior Director, Global Regulatory Affairs Project Management. The ideal candidate will have an in-depth understanding of oncology drug development and demonstrated hands-on regulatory project management experience supporting early- and late-stage registrational programs, including the execution of global new drug marketing applications, in alignment with corporate objectives. Core Responsibilities: - Project manages regulatory submissions from initiation through submission, ### Senior Director, Biostatistics, Europe - Revolution Medicines - Location: Remote (Switzerland) (remote) - Salary: Not disclosed - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7694347003 - Excerpt: Senior Director, Biostatistics, Europe Remote (Switzerland) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and the subject matter expert (SME) in Biostatistics within the Quantitative Sciences function, this position is to provide statistical leadership and support for EU access strategies, healthcare technology assessments and regulatory submissions. - Serve as the statistical lead for European access strategies, ensuring alignment between Global Clinical Development, European regulatory (EMA, MHRA, Swissmedic...) and regional/local Market Access needs to support successful European launches in collaboration with global and regional crossfunctional teams. - Partner with Regional and Local Market Access and HEOR functions to design and lead/oversee the execution of statistical analyses required for value dossiers, including PICO, indirect treatment comparisons, network meta-analyses, and RWE generation. - Partner closely with the development statistical lead, provide statistical support for EU regulatory interactions, including EMA Scientific Advice, MAA, Type II variations, and post-authorization commitments. - Ensure statistical methodologies ### Senior Project Coordinator, Global Commercialization - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $106K-$132K - Posted: 2026-04-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7613767003 - Excerpt: Senior Project Coordinator, Global Commercialization Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Project Coordinator will be part of the Commercialization Effectiveness and Operations (CE&O) team. The role is essential to the execution and achievement of goals and objectives of the CE&O, Global Commercial Development and Global Market Access teams taking on accountability for project execution and logistical coordination across leadership and team members including: - Provides project planning and executional support for key events, activities and initiatives. Might need to travel for large events to ensure program components, materials, stakeholders, timelines and logistics are aligned for successful execution. - Leads meeting support, coordinates logistics, and partners with functional leaders in creation, preparation, organization and communication of key meeting materials for key meetings. - Serves as a coordination point across various stakeholders including leaders and team members at all levels, cross functional business partners and external vendors/ agencies. - Establishes processes, timelines and milestones to ### Director, Global Pre-Approval Patient Access - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $201K-$251K - Posted: 2026-05-27 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7613323003 - Excerpt: Director, Global Pre-Approval Patient Access Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of Global Pre-Approval Patient Access will lead the strategy, design, and execution of global early access programs for Revolution Medicines' pipeline. This role is critical to enabling appropriate patient access to investigational therapies targeting RAS-addicted cancers while ensuring alignment with clinical development/operations, regulatory requirements, and company priorities. This role will report into the Head of Advocacy and Society Engagement and play an integral role in our commitment to supporting appropriate patient access to medicines. - Develop and support global early access strategy aligned with clinical and regulatory milestones; ensure distinction with other patient access initiatives considered or implemented. - Design and implement free of charge named-patient and cohort early access programs globally. - Serve as overall cross-functional leader of the programs, liaising across Clinical, Regulatory, Medical Affairs, Commercial, Legal, Supply Chain, as needed. - Establish governance for global evaluation , and prioritization ### Senior Scientist I, Clinical Biomarker Development - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $149K-$186K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695669003 - Excerpt: Senior Scientist I, Clinical Biomarker Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Scientist I in Clinical Biomarker Development team, within the Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline. You will: - Design and execute clinical biomarker strategies to support early response monitoring, patient stratification, and understanding resistance mechanisms. - Support biomarker implementation for early- and late-stage oncology clinical trials. - Oversee biomarker assay development, qualification, and sample analysis in collaboration with internal teams and external CROs. - Analyze and interpret biomarker data in the context of clinical outcomes and present results to cross-functional teams. - Contribute to clinical protocols, study reports, and regulatory documents (e.g., INDs, IBs, CSRs). - Translate preclinical findings into clinically actionable biomarker hypotheses. - Stay current with emerging biomarker technologies and trends in precision oncology. Required Skills, Experience and Education: - PhD ### Associate Principal Statistical Analyst - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-05-06 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7721649003 - Excerpt: Associate Principal Statistical Analyst Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Position requires 14+ years of Statistical Programming experience with exploratory-stage oncology clinical trials, providing programming support and oversight of one or more clinical programs (early or late phase) within Statistical Programming function. In addition to hands-on Programming, this position requires providing oversight and programming support and guidance for internal deliverables and regulatory submissions while ensuring conformance to CDISC standards and submission guidelines. Based on company needs, this position will be required to lead one or more early Phase or late phase studies/programs. Specific responsibilities include: - Effective collaborating with cross functional teams to provide programming timelines for various deliverables. - Provide SAS Programming technical support and guidance to programming team. - Oversight/participation in any internal/mock or regulatory authority audits. - Timeline and vendor management for deliverables, including submission-related activities, complying with regulatory standards (e.g., FDA 21 CFR Part 11, GxP). - Oversee the ### Senior Director & Therapeutic Area Head, Regulatory Affairs - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695273003 - Excerpt: Senior Director & Therapeutic Area Head, Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: - Provide management and leadership of one or more therapeutic areas for late-stage oncology programs. - Oversee the development of global regulatory therapeutic area and product strategies to drive product development, global registration, , and effective regulatory agency interactions. - Provide regulatory expertise and guidance to therapeutic area commercialization teams and other governance bodies. - Foster the career development of staff within the therapeutic area and contribute to departmental leadership activities. - Ensure alignment and consistency across programs within a therapeutic area based on regulatory intel, research, and competitive landscape. Primary Responsibilities: - Direct the development of global regulatory strategy from registrational studies to marketing application across one or more therapeutic areas. - Lead and mentor GRLs/Study Leads in the development of global regulatory strategies, in partnership with regional regulatory leads, including precedence, risk management and contingency planning. - ### Associate Director, Accounting - Japan - Revolution Medicines - Location: Remote (Japan) (remote) - Salary: Not disclosed - Posted: 2026-05-21 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7742334003 - Excerpt: Associate Director, Accounting - Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an experienced, strategic, and hands-on accounting leader to build and scale the accounting and finance operations infrastructure in Japan. Reporting directly to the Head of Finance & Operations, Japan, this newly created role will play a critical role in supporting the company's transition toward future commercial readiness and long-term growth in Japan. This position will lead core accounting operations, financial systems implementation, process design, internal controls, and statutory compliance, while partnering cross-functionally to establish a scalable and compliant finance environment capable of supporting a commercial-stage organization. The role will also serve as a key business partner across Finance, Commercial, Legal, Supply Chain, HR, and global teams to help prepare the organization for future product launches and increasing operational complexity. The ideal candidate combines strong technical accounting expertise with operational leadership, systems implementation experience, and the ability to build processes and infrastructure ### Senior Director, HEOR/RWE GI - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695585003 - Excerpt: Senior Director, HEOR/RWE GI Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, HEOR/RWE is a leader within the organization, responsible for developing an HEOR/RWE strategy and executing HEOR plans and activities related to Revolution Medicines assets intended for use in pancreatic and colorectal cancer. They will be accountable for demonstrating the value of Revolution Medicines products to healthcare organizations, allowing them to make informed decisions. They will work closely with the Medical Affairs team as well as other cross-functional teams to optimize the Integrated Evidence Plan (IEP) and to deliver evidence supporting the use of Revolution Medicines products. The candidate must also be able to provide input and strategic guidance on the global value of the product as well as have demonstrated success in evidence generation globally. The Senior Director HEOR/RWE will participate with the matrix team across the function to ensure alignment of all activities with the strategic and tactical plans. This individual ### Senior Director, Head of Early Development Regulatory Affairs - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695578003 - Excerpt: Senior Director, Head of Early Development Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Head of Early Development Regulatory Affairs will lead global regulatory strategy for early-stage programs (pre-IND through Phase 2) across the portfolio. This leader will shape innovative and efficient regulatory pathways that enable rapid, science-driven development while positioning assets for long-term success. In addition to strategic leadership, this role will build and scale fit-for-purpose regulatory processes, frameworks, and capabilities to support portfolio growth. The position reports to the Head of Regulatory Sciences and serves as a key member of the Regulatory leadership team. Primary Responsibilities: Early Development Strategy - Lead global regulatory strategy from candidate selection through end-of-Phase 2. - Shape early clinical development strategy by providing regulatory leadership on dose-finding approaches and indication selection that enable accelerated and differentiated development pathways and position asset for global registration and Health Authority Engagement. - Oversee strategy and cross ### Senior Director, Market Access, Italy - Revolution Medicines - Location: Remote (Italy) (remote) - Salary: Not disclosed - Posted: 2026-04-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7717868003 - Excerpt: Senior Director, Market Access, Italy Remote (Italy) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Market Access is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. This role shapes reimbursement and access strategy, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities. This position will partner with commercial and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as driving pricing strategy activities, and lead the activities to deliver access results supporting the overall success of the product launches. Responsibilities: - Lead Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the Italian healthcare system. - HTA & Pricing Filings: Lead preparation and submission of value dossiers, ### Senior Director, Medical Affairs, Spain - Revolution Medicines - Location: Remote (Spain) (remote) - Salary: Not disclosed - Posted: 2026-04-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7717891003 - Excerpt: Senior Director, Medical Affairs, Spain Remote (Spain) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, General Manager, Spain the Senior Director, Medical Affairs, Spain is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the spanish Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that Spanish medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the spanish medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as the Medical Affairs lead for Spain, accountable for local medical strategy, execution, and impact ### Senior RAS and Power Management Firmware Architect - NVIDIA Corporation - Location: 3 Locations (unspecified) - Salary: Not disclosed - Posted: 2026-06-01 - 401(k) match: listed (not source-backed) - Apply: https://nvidia.wd5.myworkdayjobs.com/NVIDIAExternalCareerSite/job/Israel-Yokneam/Senior-RAS-and-Power-Management-Firmware-Architect_JR2018727 - Excerpt: Senior RAS and Power Management Firmware Architect 3 Locations posted: Posted 11 Days Ago ### Senior Director, Regional Medical Science Liaison Team Lead - East - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $268K-$295K - Posted: 2026-04-17 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7703637003 - Excerpt: Senior Director, Regional Medical Science Liaison Team Lead - East Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Sr. Director will manage and coach a lung regional field medical team, oversee the regional field implementation plan and develop, deploy, and monitor key performance indicators and encourage individual professional development goals across the team. You will drive regional thought leader engagement strategy, foster scientific exchange, and lead insight generation strategies. Importantly, you will foster and identify opportunities to collaborate across functions and be instrumental in launch planning and execution. We are seeking a highly motivated and experienced leader to join our team as a Lung Regional Manager of Medical Science Liaisons. Key aspects of this front-line manager role will include: developing, mentoring, and coaching a team of MSL direct reports across approximately one half of the country. Required Skills, Experience and Education: - Collaborates with Field Medical Executive ### Senior Manager, Sales Operations & Analytics - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $150K-$189K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7697166003 - Excerpt: Senior Manager, Sales Operations & Analytics Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Sales Operations & Analytics, reporting to the Senior Director, Sales Operations & Analytics, plays a key role in enabling US Commercial field teams to execute with clarity and impact. This leader partners cross-functionally to translate strategy into scalable processes, actionable insights, and effective, pragmatic, high-impact tools that drive alignment and position the field for success. This individual will support seamless, coordinated commercial field enablement through: Field Operations & Governance - Translate commercial strategy into clear, compliant, and executable field processes. - Lead operating cadence, governance forums, and communications to drive alignment and accountability. - Maintain SOPs and field standards to ensure consistent execution. Sales Systems, Territory & Data - Oversee operations and infrastructure of core field enablement systems including CRM, alignment management, roster management, and sales crediting. - Ensure data integrity, system adoption, territory accuracy, and reporting reliability. - Lead ### Associate Director, Regulatory Operations - Systems - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7693857003 - Excerpt: Associate Director, Regulatory Operations - Systems Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Regulatory Operations Systems role contributes to the development, implementation, and governance of regulatory operation systems. This role serves as the subject matter expert for RIM, regulatory operation infrastructure, driving submission excellence, process optimization, compliance readiness, and system innovation across the Regulatory organization in line with global regulatory expectations and Global Regulatory Affairs (GRA) technology roadmap. Core responsibilities include driving RIM and other RO systems projects across the business, guiding the team through challenges and aligning with the overall business strategy and business development. - Support and lead activities related to regulatory operation infrastructure and system maintenance, guiding the team through challenges and aligning with the overall business strategy. - Contributes to the development, implementation, and governance of RIM and publishing system. - Provides independent leadership and direction on regulatory specifications for RIM systems, working closely with cross-functional teams ### Senior Manager, Compliance - Field Commercialization (East) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $164K-$205K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695675003 - Excerpt: Senior Manager, Compliance - Field Commercialization (East) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Compliance - Field Commercialization is responsible for providing hands-on support to Commercial and Medical field teams during product commercialization and indication expansion. This role serves as a primary field-facing compliance partner, ensuring compliant execution of field activities while enabling business objectives. Reporting to the Senior Director, Compliance the Senior Manager will implement and continuously enhance a comprehensive field-facing compliance program, embedding compliance into daily field operations while supporting the company's growth as commercial stage oncology organization. Field Compliance Support - This role will support the Senior Director, Compliance in providing field-facing corporate compliance support for all Revolution Medicines (RevMed) field roles, including field Sales, field Marketing, Medical Science Liaisons, and field Reimbursement and Access teams. - This role will serve as primary compliance contact for questions related to field activities. - The Senior Manager will partner with Headquarter Compliance, ### Senior Manager, Compliance - Field Commercialization (West) - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-04-30 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7648499003 - Excerpt: Senior Manager, Compliance - Field Commercialization (West) Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Compliance - Field Commercialization is responsible for providing hands-on support to Commercial and Medical field teams during product commercialization and indication expansion. This role serves as a primary field-facing compliance partner, ensuring compliant execution of field activities while enabling business objectives. Reporting to the Senior Director, Compliance the Senior Manager will implement and continuously enhance a comprehensive field-facing compliance program, embedding compliance into daily field operations while supporting the company's growth as commercial stage oncology organization. Field Compliance Support - This role will support the Senior Director, Compliance in providing field-facing corporate compliance support for all Revolution Medicines (RevMed) field roles, including field Sales, field Marketing, Medical Science Liaisons, and field Reimbursement and Access teams. - This role will serve as primary compliance contact for questions related to field activities. - The Senior Manager will partner with ### Senior Director, Economic Modeling - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695564003 - Excerpt: Senior Director, Economic Modeling Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Economic Modeling is responsible for defining and executing the economic modeling strategy to produce high quality health economic models & modeling strategies across Rev Meds portfolio. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in Oncology. Key Strategic Responsibilities: - Lead the development of strategic and operational plans for health economic modeling within Global HEOR & RWE (e.g., early and submission cost-effectiveness / utility models, budget impact models, and country adaptations) while ensuring alignment with Integrated Evidence Plans and appropriate Global stakeholders. - Partner with Global HEOR & RWE Executive Directors on core health economic modeling plans to support HTA, payer, and other access stakeholder assessments, submissions, negotiations, including associated value/HTA deliverables and publications to meet business and access objectives. - Provide strategic, methodological ### KSA MEA North Revenue Operations Business Partner (Riyadh Based) - SAP - Location: Country Saudi Arabia | Internal Posting Location Riyadh (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Parental leave: 6 weeks (not source-backed) - Non-birth-parent leave: 6 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://jobs.sap.com/job/Riyadh-KSA-MEA-North-Revenue-Operations-Business-Partner-%28Riyadh-Based%29-11435/1384568033/ - Excerpt: KSA MEA North Revenue Operations Business Partner (Riyadh Based) Country Saudi Arabia | Internal Posting Location Riyadh We help the world run better At SAP, we keep it simple: you bring your best to us, and we'll bring out the best in you. We're builders touching over 20 industries and 80% of global commerce, and we need your unique talents to help shape what's next. The work is challenging - but it matters. You'll find a place where you can be yourself, prioritize your wellbeing, and truly belong. What's in it for you? Constant learning, skill growth, great benefits, and a team that wants you to grow and succeed. PURPOSE & OBJECTIVE: The MEA North RevOps Business Partner's mission is to boost field productivity, improve business predictability and support executive decision-making. Supporting Key Stakeholders (while being based in Egypt), the ideal candidate should understand all operations processes, tools, and technical KPIs. From an annual perspective, most of a BP focus will be on Sales Planning, Demand Management, and Deal Execution, followed by Performance Management, Go to Market and Cloud Renewals. A RevOps Business Partner's success is based on key core priorities: Their stakeholders' success and feedback. Increased productivity through adoption of standards (tools & processes). Speed to execute through increased transparency and by sharing successes/learnings. Be on top of the Cloud Renewals story (understanding the Customer Value Journey story) JOB DESCRIPTION Forecasting: Secure consistent and disciplined execution of FC practices Ensure a smooth, accurate and consistent running o ### Associate Director, Biostatistics – Early Phase - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-04-23 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7712274003 - Excerpt: Associate Director, Biostatistics – Early Phase Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This position is to serve as a study level statistician for oncology studies, and to coordinate activities with other functional groups to ensure timely deliverables. - Represent biostatistics on study/project teams. - Provide statistical expertise for design, analysis and reporting of clinical studies. - Collaborate with various functions on study design and planning, protocol development, statistical methodology and analysis. - Develop statistical analysis plans and analysis specifications. - Collaborate with statistical programming to ensure that analysis is conducted per statistical plan and specifications. - Collaborate with data management and clinical operations to ensure robust CRF and database development and quality data collection. - Provide statistical input to regulatory interaction and response to health authority submissions. - Collaborate in publications, assist in data interpretation, and ensure consistency and accuracy in data presentation. - Contribute to the development of functional-level standards, SOPs, and ### Senior Director, Global Medical Affairs - GI Oncology - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-05-13 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7648531003 - Excerpt: Senior Director, Global Medical Affairs - GI Oncology Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the GI Tumors Medical Affairs Strategy Lead, the Senior Director, Global Medical Affairs, will be responsible for developing and executing the Global Medical Affairs (GMA) strategy and tactical plans with a focus on launch readiness, launch implementation and life cycle management for an individual asset. The successful candidate will have a proven track record of developing and driving medical strategies with a focus on effectively communicating key scientific data through publications, medical information, medical communications, and congress activities. The successful candidate will also have experience gathering and analyzing insights through Advisory Boards, Key Opinion Leader (KOL) engagements and interaction with local/regional medical teams and translating those insights into tactics that optimize asset utilization and impact the drug lifecycle. This role requires close collaboration with cross-functional counterparts across Development, Research and Commercial as well as other internal partners, ### Senior Pega Systems Engineer - Unisys CORP - Location: Bangalore, KA, India (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://unisys.wd5.myworkdayjobs.com/External/job/Bangalore-KA-India/Senior-Pega-Systems-Engineer_REQ570151 - Excerpt: Senior Pega Systems Engineer Bangalore, KA, India Bangalore, KA, India What success looks like in this role: Role Summary The Senior Pega System Architect (SSA) will play a critical role in designing, implementing, and governing a Pega Constellation-based Customer Service solution for Government. The role is responsible for developing the solution that aligns with government policies, security standards, accessibility requirements, and service delivery outcomes, while leveraging Pega Customer Service, Case Management, and Omni-Channel capabilities. The SSA will work closely with business stakeholders, Lead system architects, security teams, and delivery squads to translate complex service delivery requirements into scalable, maintainable Pega solutions. What success looks like in this role High-quality Pega solution delivered in line with Constellation architecture and Pega Guardrails Design and implement Pega solutions that are scalable, efficient, and aligned with business requirements. Complex case types, service intents, and flows implemented accurately Constellation-based UI built using out-of-the-box views and DX APIs with minimal customisation Integrations implemented reliably with strong error handling and performance Features delivered on time and with minimal rework Solutions that meet government security, privacy, and accessibility requirements Reduced defects through strong unit testing and peer reviews Provide technical guidance and mentorship to junior architects and developers. Troubleshoot and resolve complex technical issues. Manage the technical aspects of deployment and post-implementation support. Keep abreast of the latest Pega technologies and functionalities, advocating for their use to improve project outcomes. You will be successful in this role if you have Strong hands-on experience building complex Pega case management ### Associate Director, Global Quality System & Compliance - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-04-29 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7719794003 - Excerpt: Associate Director, Global Quality System & Compliance Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: - Provide strategic and operational leadership to scale and globalize the Quality Management System (QMS), establishing a harmonized, flexible framework that supports international growth and regulatory compliance. - Lead oversight and expansion of core quality systems across global sites, including document control, GxP training, quality events, supplier management, audits, and batch release. - Partner with regional teams (including Japan, Europe & other global regions) to integrate local regulatory requirements into the global QMS while maintaining global consistency. - Establish and govern global quality procedures, including policies, SOPs, and standardized processes to ensure compliance and operational efficiency. - Ensure inspection readiness and lead support for global health authority inspections, regulatory submissions, and product launches. - Oversee global quality metrics, compliance monitoring, and management review processes; drive proactive identification, escalation, and mitigation of quality risks. - Provide governance for electronic quality and ### GTM Engineer - Cresta - Location: United States (Remote) (remote) - Salary: $150K-$230K - Posted: 2026-02-17 - Apply: https://job-boards.greenhouse.io/cresta/jobs/5123589008 - Excerpt: GTM Engineer United States (Remote) Cresta unlocks the true potential of the customer experience, turning every conversation into a competitive advantage. Cresta's unified AI platform combines conversational AI agents, real-time human agent augmentation, and comprehensive conversation intelligence to drive revenue and efficiency gains across every channel. The world's leading companies, including United Airlines, Cox Communications, and Marriott, use Cresta to power world-class customer experiences every day. Born from the Stanford AI Lab, Cresta has raised more than $270 million from the world's leading investors, including a16z, Greylock, and Sequoia. Cresta's leadership includes some of the leading minds in AI today. Our CEO, Ping Wu , founded and led Google's Contact Center AI and Vertex AI platforms before joining Cresta to build the future of AI-driven customer experiences. Over the next few years, AI is going to redefine how people all over the world interact with businesses every day. Come build that future at Cresta. GTM Engineer Cresta's mission is to help companies turn conversations into their competitive advantage. We build AI that helps the world's largest enterprises unlock revenue, efficiency, and insight from every customer interaction. We are hiring a GTM Engineer to rebuild how go to market works. This role is about eliminating manual work, helping our teams focus on the right accounts, and building systems that make winning easier. You will work directly with our CEO, CRO, CMO, and Rev Ops leadership to design and deploy an AI native operating system for our revenue engine. Location: Remote / ### Senior Director, Medical Affairs, Midsized Markets Europe - Revolution Medicines - Location: Basel, Basel-Stadt, Switzerland (unspecified) - Salary: Not disclosed - Posted: 2026-05-05 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7725127003 - Excerpt: Senior Director, Medical Affairs, Midsized Markets Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, GM, Midsized Markets, the Senior Director, Medical Affairs, Midsize Markets Europe, is the medical leader responsible for defining and executing the medical strategy for oncology products in our portfolio within Midsized markets. This role serves as the medical voice within the Midsized markets Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that Midsized markets medical considerations are embedded in the regional medical strategy and plans and will partner with the Midsized markets country managers and crossfunctional teams, as well as VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Midsized markets medical team and working closely with the Global, Regional, Country Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as ### Scientific Writer, Integrated Research Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $143K-$178K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695440003 - Excerpt: Scientific Writer, Integrated Research Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Scientific Writer with strong nonclinical regulatory experience to support the authoring and integration of nonclinical content for U.S. and global regulatory submissions. This role focuses on developing and integrating nonclinical content beyond INDs and NDAs, including briefing documents, Investigator Brochures, responses to health authority questions, and other submission-related materials across the U.S., Europe, and Asia. As a strategic scientific integrator, this individual will translate complex RAS biology and translational pharmacology into clear, compelling regulatory narratives that reflect RevMed's deep mechanistic understanding of RAS signaling and frontier targets. The role partners closely with nonclinical subject matter experts (SMEs) in pharmacology, toxicology, and DMPK, as well as Regulatory Affairs, Regulatory Operations, and Medical Writers, to ensure nonclinical strategy and content are scientifically rigorous, aligned, and submission-ready. The Scientific Writer will leverage structured source documents, document management systems, and emerging AI-enabled ### Senior Director, Regional Medical Science Liaison Team Lead - West - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $268K-$295K - Posted: 2026-04-17 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7703639003 - Excerpt: Senior Director, Regional Medical Science Liaison Team Lead - West Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Field Medical Affairs, the Sr. Director will manage and coach a lung regional field medical team, oversee the regional field implementation plan and develop, deploy, and monitor key performance indicators and encourage individual professional development goals across the team. You will drive regional thought leader engagement strategy, foster scientific exchange, and lead insight generation strategies. Importantly, you will foster and identify opportunities to collaborate across functions and be instrumental in launch planning and execution. We are seeking a highly motivated and experienced leader to join our team as a Lung Regional Manager of Medical Science Liaisons. Key aspects of this front-line manager role will include: developing, mentoring, and coaching a team of MSL direct reports across approximately one half of the country. Required Skills, Experience and Education: - Collaborates with Field Medical Executive ### Associate Director, Learning & Engagement - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-27 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7749061003 - Excerpt: Associate Director, Learning & Engagement Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This is an exciting opportunity to lead the Learning & Engagement initiatives. The Associate Director, Learning & Engagement will lead the design, development and implementation of learning initiatives, instructional design solutions, learning forums, and infrastructure initiatives across partnered functions and in close alignment with HR and RevMed Learning and Engagement functions' best practices. This role requires a blend of Learning & Development expertise, a solid understanding of drug development processes & skillsets, and the communication abilities to support a diverse portfolio of strategic growth initiatives. Responsibilities: - Lead and deliver innovative learning programs that support the implementation and continuous improvement of DCS Growth & Enablement strategic roadmap and initiatives. - Drive the adoption of new business processes through training, communication, knowledge management, and change management. - Collaborate within Business Operations and across department leaders and functional subject-matter experts to assess training needs, ### Senior Director, Medical Affairs, UK - Revolution Medicines - Location: London, England, United Kingdom (unspecified) - Salary: Not disclosed - Posted: 2026-04-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7717896003 - Excerpt: Senior Director, Medical Affairs, UK London, England, United Kingdom Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, General Manager, UK the Senior Director, Medical Affairs, UK is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the UK Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that UK medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the UK medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as the Medical Affairs lead for UK, accountable for local medical strategy, execution, ### Pega Senior Developer Assistant Vice President - Citigroup Inc. - Location: CHENNAI, Tamil Nādu, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - 401(k) match: listed (not source-backed) - Apply: https://citi.eightfold.ai/careers/job/859034907568 - Excerpt: Pega Senior Developer Assistant Vice President CHENNAI, Tamil Nādu, India ### Director, GLP Quality Assurance - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-05-01 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7613313003 - Excerpt: Director, GLP Quality Assurance Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: - The Director, Good Laboratory Practice Quality Assurance (GLP QA) is responsible for ensuring Good Laboratory Practices (GLP) compliance at RevMed and external vendors contracted to perform regulated work on behalf of RevMed including all GLP vendors. - Responsibilities include research laboratory vendors that perform work to support regulated clinical studies. - Develops the annual vendor audit plan. - The Director GLP QA performs and/or manages vendor audits including: - Development of the audit plan, audit conduct, and reporting - Tracking and coordination of audit closure tasks including review of observation responses from vendor(s) in conjunction with operational subject matter experts (SMEs), as applicable. - Provision of vendor approval recommendations - Maintenance of vendor approval status in Veeva. - Development and/or review of Quality Agreements - Performs or participates in internal audits. - Provides QA review of CRO study protocols and reports for ### Director, Quality Assurance, Japan - Revolution Medicines - Location: Remote (Japan) (remote) - Salary: Not disclosed - Posted: 2026-05-15 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7694172003 - Excerpt: Director, Quality Assurance, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Quality Assurance professional to serve as Quality Assurance (Hinseki) for its Japan entity. This role has a primary focus on quality management and quality oversight, including quality systems, manufacturing and supply chain quality, and CMC-related quality activities. In addition, the position will serve as the Quality Assurance (Hinseki) as defined under the Japanese GQP Ordinance, supporting the establishment and maintenance of the Japan Marketing Authorization Holder (MAH). The position also works closely with Marketing Supervisor General (Soseki) and Safety Manager (Anseki) as part of the legally required three-role framework, ensuring effective governance, communication, and decision-making across quality and safety domains. Key Responsibilities： - Lead quality management and quality oversight activities for the Japan entity, including the design, implementation, and maintenance of quality systems appropriate for a pre-commercial and early-stage organization. - Ensure integration of Japan specific requirements into global quality management ### Senior Manager, Commercial Regulatory Affairs - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695672003 - Excerpt: Senior Manager, Commercial Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Senior Manager, Commercial Regulatory Affairs to partner closely with the cross-functional teams to ensure that all promotional and medical communication strategies are compliant with applicable regulations, industry standards, and internal policies. This role will help enable successful product commercialization while upholding regulatory integrity and scientific accuracy. As part of the Regulatory Affairs function, the Senior Manager will work under supervision to provide strategic regulatory advice on advertising/promotion and medical materials to the US organization for assigned products in accordance with business goals and objectives, FDA regulations/guidances, pharma guidelines, and company policy. The position can be based at our Redwood City, CA site in a hybrid work schedule (preferred) or remote-based with quarterly and as needed travel. Required Skills, Experience and Education: - Serves as a primary or secondary regulatory advertising and promotion reviewer for assigned products on ### Senior Clinical Data Manager - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $138K-$172K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695503003 - Excerpt: Senior Clinical Data Manager Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Opportunity: The Senior Clinical Data Manager is responsible for all aspects of the data management process from the development of project documentation, system set-up, User Acceptance Testing (UAT), routine data review through database lock of clinical trials. The Sr/CDM has a broad, fundamental knowledge of the data management process and can plan, manage and coordinate all Data Management activities for assigned study(ies) with minimal guidance. This person may have project level oversight of junior data managers and/or Clinical Data Associates (CDAs). The core duties and responsibilities of the Sr/CDM are delineated below. Specifically, you will be responsible for: - Represents data management in study team meetings, able to facilitate and provide data management updates and/or input when appropriate. - Manages data management timelines to coordinate and synchronize deliverables with the overall study timelines. - Generates and/or reviews/approves study documents (e.g. Data Management Plans, Case Report ### Associate Director, Clinical Quality Assurance - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-05 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7722995003 - Excerpt: Associate Director, Clinical Quality Assurance Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an Associate Director, Clinical Quality Assurance, who will play a key role within Quality Assurance and is responsible for providing leadership and compliance support for RevMed sponsored clinical trials with respect to RevMed's Standard Operating Procedures, applicable regulatory requirements (FDA, EU, ICH & country-specific), and current industry standards and practices. - Support the development and maintenance of applicable Quality Systems and procedures that comply with applicable GCP standards and guidelines. - Collaborate with clinical functions (e.g., Clinical Operations, Clinical Development) to provide GCP compliance support. - Participate in clinical study execution teams (CSETs) to enable risk-based quality management and a culture of quality and open dialogue. - Perform quality review of clinical trial documents with a focus on compliance / regulatory requirements and risk management. - Collaborate with internal stakeholders, external auditors, and auditees to support the planning, ### Junior Analyst, Pega - Accendra Health INC - Location: 3610 Accendra India (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - Parental leave: 3 weeks (not source-backed) - Non-birth-parent leave: 3 weeks (not source-backed) - Apply: https://owensminor.wd1.myworkdayjobs.com/OMCareers/job/3610-Accendra-India/Junior-Analyst--Pega_REQ_25_24851 - Excerpt: Junior Analyst, Pega 3610 Accendra India At Owens & Minor, we are a critical part of the healthcare process. As a Fortune 500 company with 350+ facilities across the US and 22,000 teammates in over 90 countries, we provide integrated technologies, products and services across the full continuum of care. Customers-and their patients-are at the heart of what we do. Our mission is to empower our customers to advance healthcare, and our success starts with our teammates. POSITION SUMMARY Owens & Minor delivers significant and sustained value across the breadth of the Healthcare industry - from acute care to patients in their homes, Through Apria & Byram Healthcare. Our innovative company is looking to fill the role of Junior Analyst, Pega Systems. While this is our ideal list, we will consider candidates that do not necessarily have all the qualifications but have sufficient experience and talent. ESSENTIAL JOB FUNCTIONS: • Respond to and resolve day to day issues reported by users based on SLA timelines. • Defect fixes and debugging using clipboard, Tracer and Live UI tool. • Utilize PDC for monitoring, trouble shooting and debugging of solutions. • Knowledge in Creating Pega Cloud Ticket / Requests. • Take lead to manage incidents and guide the teammates. • Escalate complex issues to appropriate team and level, serve as communication point for involved resources. • Perform day-to-day system maintenance tasks Like Production health. • Understand the design and can support Analysis/Implementation of PEGA Enterprise Class Rules, Flows, Activities, Correspondence, Case Management ### Vice President, Regulatory Affairs - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $294K-$367K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695252003 - Excerpt: Vice President, Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Vice President, Regulatory Affairs will manage several key U.S. based regulatory functions and report to the SVP of Regulatory and Quality. The position is responsible for expanding and leading a large, high functioning regulatory group and ensuring global alignment. - Provide ethical and mission-driven leadership of the Regulatory Affairs functions. Embody and practice the company's mission-driven culture. Ensure that our core values guide our strategic vision and our day-to-day decision making. - Provide a vision for the Regulatory Affairs organization and develop a plan to achieve it. Design and rapidly scale a group to meets the needs of an explosive pipeline in areas of high unmet medical need and intense industry competition. - Influence decision-making of senior leadership and ensure globally aligned regulatory decision-making. - Collaborate closely and form effective relationships with other functional heads and regional counterparts to ensure high quality, ### Director, Medical Information, Japan - Revolution Medicines - Location: Remote (Japan) (remote) - Salary: Not disclosed - Posted: 2026-05-15 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7687157003 - Excerpt: Director, Medical Information, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a motivated and experienced professional to join our team as a Director of Medical Information supporting Japan. This role focuses on ensuring the delivery of timely, accurate, and evidence-based responses to healthcare professionals (HCPs), patients, and caregivers. As a key member of the Medical Affairs team, you will oversee the creation and management of medical information content, provide scientific and operational oversight of Japan medical information call center team, contribute to medical booth asset creation, and contribute to dossier development and review. This role will also provide Medical Information support at scientific congresses and collaborate cross-functionally to support both pipeline assets and companion diagonstics. The ideal candidate is a skilled communicator with a strong scientific background and can manage projects in a dynamic environment. This role will report to the Head of Medical Information within the Global Medical Excellence team. Key Responsibilities: - ### Director, Human Resources Technology – Workday Architect - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-05-27 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7648497003 - Excerpt: Director, Human Resources Technology – Workday Architect Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a rapidly growing biotech company, we are scaling our enterprise systems to support a dynamic workforce, evolving regulatory requirements, and complex financial operations. We are seeking a Workday Architect person to lead the design, development, and optimization of our Workday platform. - Oversee the end-to-end architecture, governance, and optimization of the Workday ecosystem including HCM, Learning, Talent, Peakon, Sana, and Advanced Compensation etc. - Provide architectural oversight and governance for external implementation partners, AMS providers, and integration vendors to ensure alignment with enterprise standards and strategic objectives. - Drive enterprise architecture decisions across the HR technology ecosystem by partnering with IT Enterprise Architecture, IT Security, and Finance teams to ensure scalable, compliant, and business-aligned solutions across Workday and interconnected enterprise platforms. - Lead adoption and governance of AI-enabled HR technologies, intelligent automation, and digital workflow capabilities across the Workday ### Associate Director, Integrated Research Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695514003 - Excerpt: Associate Director, Integrated Research Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Integrated Research Management provides leadership across Research disciplines to strengthen operational execution, organizational clarity, and cross-functional alignment within the Discovery organization. This role translates Research strategy into actionable discipline-level plans and drives operational effectiveness within and across scientific teams. The Associate Director partners with Research leadership to identify business and scientific challenges, improve operating frameworks, and implement scalable solutions that support Discovery performance and organizational growth. - Translate Research strategy into clear operating plans and drive disciplined execution across Discovery workflows. - Establish and enforce operational objectives, processes, and decision frameworks that improve cross-disciplinary coordination and execution performance. - Diagnose and resolve complex operational challenges, removing friction and strengthening clarity, speed, and accountability in program advancement. - Lead and implement change initiatives within Research, ensuring stakeholder alignment and sustained adoption of improved processes and digital tools. - Partner directly ### Senior Director, Medical Affairs, France - Revolution Medicines - Location: Paris, France (unspecified) - Salary: Not disclosed - Posted: 2026-04-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7717880003 - Excerpt: Senior Director, Medical Affairs, France Paris, France Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, General Manager, France the Senior Director, Medical Affairs, France is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the French Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that French medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the French medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as the Medical Affairs lead for France, accountable for local medical strategy, execution, and impact ### Director, Medical Information - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $201K-$251K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695099003 - Excerpt: Director, Medical Information Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a motivated and experienced professional to join our team as a Director of Medical Information. This role focuses on ensuring the delivery of timely, accurate, and evidence-based responses to healthcare professionals (HCPs), patients, and caregivers. As a key member of the Medical Affairs team, you will oversee the creation and management of medical information content, support compendia submissions, and provide Medical Information support at congresses. The ideal candidate is a skilled communicator with a strong scientific background and can manage projects in a dynamic environment. Key Responsibilities: - Lead oversight and performance management of the global Medical Information call center, ensuring all customer inquiries are handled accurately, compliantly and within established timelines. - Maintains and monitors KPIs, and quality metrics, driving continuous improvement to ensure high-quality, consistent inquiry handling. - Prepares and presents regular reports on medical information performance metrics and outcomes to ### OFA Senior - Baker Tilly - Location: IND KA Bangalore - Cherry Hills (unspecified) - Salary: Not disclosed - Posted: 2026-06-04 - 401(k) match: listed (not source-backed) - Apply: https://bakertilly.wd5.myworkdayjobs.com/BTCareers/job/IND-KA-Bangalore---Cherry-Hills/OFA-Senior_JR106018 - Excerpt: OFA Senior IND KA Bangalore - Cherry Hills posted: Posted 8 Days Ago ### Senior Director, Compliance Training - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-05-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7613273003 - Excerpt: Senior Director, Compliance Training Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Compliance Training will lead the strategy, design, and execution of a global compliance training program for a biotechnology organization. This role is responsible for fostering a culture of ethics and compliance by delivering engaging, risk-based training aligned with regulatory requirements and industry best practices. The ideal candidate brings deep expertise in life sciences compliance, adult learning methodologies, and global training program management. This role will work closely with Learning & Development, Corporate Communications, Legal, HR, and business stakeholders to integrate compliance and legal training into broader enterprise learning, communications, and change-management efforts. - Develop and implement a comprehensive, risk-based compliance training strategy aligned with business objectives and regulatory expectations (e.g., FDA, OIG, DOJ, EMA). - Serve as a key advisor to the Vice President, Compliance and senior leadership on training-related compliance risks and mitigation strategies. - Continuously assess and ### Java/Spring Boot/Kafka Developer Senior Associate (AC Manila) - PricewaterhouseCoopers International Limited - Location: Taguig City, Philippines (unspecified) - Salary: Not disclosed - Posted: 2026-06-08 - 401(k) match: listed (not source-backed) - Apply: https://pwc.wd3.myworkdayjobs.com/CRM_Experienced_Careers_Site/job/Manila-AC---SixNeo-Building-BGC-Taguig-City/AC-Manila---Java-Spring-Boot-Kafka-Developer-Senior-Associate_724670WD/apply - Excerpt: Java/Spring Boot/Kafka Developer Senior Associate (AC Manila) Taguig City, Philippines Join our team as a Senior Java/Spring Boot/Kafka Developer Associate and lead the design, integration, and delivery of secure, scalable solutions. Mentor junior engineers, collaborate with cross-functional teams, and drive digital transformation in a dynamic environment. Grow your expertise with cutting-edge technologies and make a real impact on business-critical systems. ### Vice President, Healthcare Law - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $333K-$383K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695398003 - Excerpt: Vice President, Healthcare Law Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Vice President, Healthcare Law, reporting to the Deputy General Counsel, to join our RevMed team. The Vice President, Healthcare Law will provide strategic legal guidance related to the company's planned commercialization activities, including related to market access, patient access programs, distribution and licensing, and regulatory submissions. A successful candidate will bring proven experience working at a publicly traded life sciences organization, with demonstrated success in driving legal cross-functional strategy. - Serve as a legal advisor to members of the executive team on a wide range of commercialization issues with broad enterprise impact. - Serve as legal representative for Commercialization and Medical-related committees and teams, including promotional review, medical materials, and educational and charitable grants. - Serve as the lead counsel for healthcare regulatory law, including the FDCA and related Regulations, and Guidance Documents, fraud and abuse laws and guidances ### Sr. Analyst GTM Tooling - Kaseya - Location: Medellin, Colombia (unspecified) - Salary: Not disclosed - Posted: 2026-06-03 - Apply: https://www.kaseya.com/careers/jobs/id/5999852004/?gh_jid=5999852004 - Excerpt: Sr. Analyst GTM Tooling Medellin, Colombia About Kaseya Kaseya is the leading provider of AI-powered IT management and cybersecurity software, serving Managed Service Providers (MSPs) and internal IT organizations worldwide. Our comprehensive platform helps organizations efficiently manage, secure, and automate their IT environments, driving operational efficiency and long-term business success. Backed by Insight Partners , a leading global software investor, Kaseya has experienced sustained double-digit growth and continues to expand its global footprint. Today, Kaseya supports customers in more than 20 countries and manages over 15 million endpoints worldwide. Founded in 2000, Kaseya has built a culture centered around innovation, accountability, and results. We are a high-growth, high-performance organization that values individuals who are driven, adaptable, and committed to delivering exceptional outcomes for our customers and teammates alike. At Kaseya, success comes from embracing challenges, moving with urgency, and continuously raising the bar. Overview The Sr. Analyst, GTM Tooling sits within the GTM Operations & Execution organization and reports to the Sr. Manager, GTM Tooling Strategy. This role is responsible for supporting the evaluation, optimization, and operational effectiveness of the GTM technology ecosystem, with a primary focus on Salesforce and seller-facing tools. This individual will drive tooling improvements by analyzing system performance, monitoring adoption and productivity metrics, identifying workflow inefficiencies, and partnering cross-functionally to support enhancements across the GTM organization. The ideal candidate is analytical, process-driven, and focused on improving seller experience through technology and operational excellence. Key Responsibilities GTM Tooling Analysis & Optimization - Support the evaluation and optimization ### Senior Director, Real World Data & Analytics - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695619003 - Excerpt: Senior Director, Real World Data & Analytics Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Real-World Data & Analytics will work with the Executive Director, Head of Epidemiology and VP of HEOR to establish the RWD&A group at RevMed, scaling organizational capabilities and leading the strategy and execution of key RWD&A deliverables for RevMed assets. They will be accountable for working across the clinical development, safety, medical affairs, commercial including analytics and insights, and IT matrix, developing strategies and leading and/or overseeing execution of key projects. Reporting to the Executive Director, Head of Epidemiology & RWD Strategy, they will closely align with the other users of RWD at RevMed, develop ways of working and communication channels to maximize RevMed's investment in RWD as well as lead the analysis (either directly or leveraging junior team members and vendors) of RWD database and other studies. This is an exceptional opportunity to contribute to the advancement of ### Senior Director, Clinical Data Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-06-09 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7766570003 - Excerpt: Senior Director, Clinical Data Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials. Key responsibilities include leading and managing data management teams, establishing and enforcing data management policies and procedures, overseeing departmental budgets, collaborating with cross-functional teams and vendors, and ensuring data management processes meet regulatory standards. This role requires extensive experience in clinical data management, strong leadership and communication skills, expertise in clinical trial methodologies, and a deep understanding of regulatory requirements including submissions and data management systems. Required Skills, Experience and Education: - Define and implement the overall vision, strategy, and goals for the clinical data management department, including developing and enforcing departmental SOPs. - Lead, manage, and develop data management teams, handling resource planning, staff training, and performance reviews. ### Director, Global Medical Affairs – GI Oncology - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7732352003 - Excerpt: Director, Global Medical Affairs – GI Oncology Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, Global Medical Affairs will report to the GI Tumors Medical Affairs Strategy Lead and will be responsible for supporting the development and execution of the Global Medical Affairs (GMA) strategy and tactical plans for Revolution Medicines assets being developed for the treatment of GI cancers, with a focus on PDAC and CRC. Key aspects of this role include the following: support the development and execution of a Healthcare Professional (HCP) engagement strategy to gather insights that shape internal programs; act as the medical representative on cross-functional teams; serve as a therapeutic area content expert; and support medical affairs functions as needed. As a member of the GMA team, the successful candidate will participate in the Global Medical Affairs Team (GMAT) to execute medical strategies, contribute to the operations and oversight of medical activities, and work cross-functionally to support ### Associate Director, Regulatory Systems - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-20 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7742279003 - Excerpt: Associate Director, Regulatory Systems Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Regulatory Business Systems will lead the strategy, governance, implementation, and optimization of Regulatory Affairs technology platforms that support global regulatory operations and submission activities. This individual will serve as the business owner for key regulatory systems and partner closely with Regulatory Affairs, Regulatory Operations, IT, Quality, Clinical, and external vendors to deliver scalable, compliant, and efficient business solutions. The ideal candidate brings deep expertise in regulatory processes, business systems management, and cross-functional collaboration within a biotechnology or pharmaceutical environment. This role will play a critical part in advancing RevMed's regulatory systems roadmap and enabling operational excellence across the regulatory organization. Key Responsibilities: - Serve as the business owner and strategic lead for Regulatory Affairs systems, including Veeva RIM, Veeva Registrations, DocuBridge, and related regulatory platforms. - Drive the long-term strategy, roadmap, and governance model for regulatory business systems aligned with ### Associate Director, Qualified Person, Europe - Revolution Medicines - Location: Remote (Netherlands) (remote) - Salary: Not disclosed - Posted: 2026-05-01 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7648529003 - Excerpt: Associate Director, Qualified Person, Europe Remote (Netherlands) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Qualified Person (QP) holds ultimate responsibility for the certification and release of medicinal products in accordance with EU GMP, Directive 2001/83/EC, Dutch pharmaceutical legislation, and applicable Marketing Authorisations. The role provides independent, authoritative quality leadership across site operations and serves as a key member of the site leadership team, ensuring patient safety, product quality, regulatory compliance, and reliable supply. In addition to batch release accountability, the QP provides strategic oversight of the Pharmaceutical Quality System, partners closely with senior stakeholders across Quality, Technical Operations, Supply Chain, and Regulatory Affairs, and represents the site in interactions with Health Authorities. - Regulatory Accountability & Product Release - Act as the legally registered Qualified Person with full authority for certification and release of clinical and commercial medicinal products. - Ensure batch certification in compliance with EU GMP, Directive 2001/83/EC, national legislation, EU GMP Annex 16, the applicable ### Director, Molecular Pathology, Translational Sciences, Translational Research. - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695103003 - Excerpt: Director, Molecular Pathology, Translational Sciences, Translational Research. Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Director, Molecular Pathology, you will be a key member of a cross-functional Translational Sciences Team, reporting to the Senior Director and Head of Translational Sciences within Translational Research and will: - Biomarker Strategy: Define and execute molecular and digital pathology-driven biomarker strategies. - Integration of Advanced Modalities: Lead adoption of molecular pathology and spatial technologies (to support translational research and broader BDR needs. - Digital & Computational Pathology: Drive implementation of whole-slide imaging, AI/ML-based image analysis, and integration of spatial biomarker analytics into decision-making. - Data Interpretation & Reporting: Provide expert interpretation of pathology data, ensuring robust correlation with clinical outcomes and mechanistic insights. - Cross-functional Leadership: Collaborate with Translational Medicine, Bioinformatics, and Clinical Development colleagues to implement candidate biomarkers into Translational Biomarker plans for RAS(ON) inhibitors in alignment with overarching clinical development strategies. Responsibilities - Scientific Leadership ### Senior Director, Pipeline & Product Communications - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695609003 - Excerpt: Senior Director, Pipeline & Product Communications Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Pipeline & Product Communications will lead the strategy, development, and execution of integrated communications across the company's pipeline and product candidate portfolio. This role is accountable for shaping how Revolution Medicines' pipeline and product narratives are understood by external stakeholders, including scientific and medical audiences, patients and advocates, media, and the broader healthcare ecosystem. Reporting to the Head of Communications, this leader will serve as a trusted strategic advisor to cross-functional partners across R&D, Medical Affairs, Regulatory, Commercial, Market Access, Patient Advocacy, Legal, and Investor Relations. The role requires deep expertise across the full product lifecycle, from early clinical development through regulatory milestones and launch readiness, and the ability to translate complex science into clear, differentiated, and credible narratives. This is a high-impact leadership role for a communications professional who thrives at the intersection of science, strategy, people ### Executive Director, Global Patient Safety Quality and Compliance - Pharmacovigilance - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $265K-$331K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695212003 - Excerpt: Executive Director, Global Patient Safety Quality and Compliance - Pharmacovigilance Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a skilled and experienced Executive Director (ED) of Global Patient Safety (GPS) Quality and Compliance to join our dynamic team. The ED GPS Quality and Compliance is responsible for the strategy, development, oversight, and execution of the pharmacovigilance quality management system (PV-QMS) within the organization. This role ensures the safety of patients and the overall positive benefit-risk of RevMed pharmaceutical products by driving compliance with global pharmacovigilance regulations and fostering a culture of safety and vigilance. The responsibilities of this role include oversight of the PV-QMS , PV training strategy, PV controlled documentation, inspection and audit management, ensuring inspection readiness, Corrective Action Preventive Action (CAPA) management, Quality Assurance (QA), and maintenance of Good Clinical Practice (GCP), and Good Pharmacovigilance Practices (GVP) in partnership with GPS management, QA, and staff. The ED of GPS Quality ### Payroll Manager - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $143K-$178K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695380003 - Excerpt: Payroll Manager Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Associate Director, Payroll, the Payroll Manager will be responsible for ensuring accurate, timely and compliant payroll processing from start to finish. This position is ideal for a payroll leader who thrives in fast-paced, ambiguous, and rapidly growing environments. The successful candidate will have deep experience in public company environments, understand stock compensation, and be well-versed in SOX compliance, audits, and employment tax. Responsibilities: - Manage full-cycle operations for the US payroll including but not limited to semi-monthly, equity, commission, off-cycle and bonus processing using ADP Workforce Now. - Support equity compensation processing including RSU, ISO, Non-Qual, and ESPP; ensuring accurate tax treatment and timely reporting. - Supervise and mentor a team of payroll professionals, providing leadership, development, and training. - Lead quarter-end and year-end payroll processes, including tax reporting, compliance filings and W-2/equivalent statement delivery. - Ensure compliance with local payroll, tax, ### Pega Architect Vice President - Citigroup Inc. - Location: CHENNAI, Tamil Nādu, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - 401(k) match: listed (not source-backed) - Apply: https://citi.eightfold.ai/careers/job/859034907552 - Excerpt: Pega Architect Vice President CHENNAI, Tamil Nādu, India ### Director, Global Regulatory Affairs Project Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-04-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7710393003 - Excerpt: Director, Global Regulatory Affairs Project Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, Global Regulatory Affairs Project Management is an integral part of the global Regulatory Affairs organization and is responsible for translating global regulatory strategies into actionable execution plans. This role applies advanced project management expertise and operational leadership to guide cross-functional teams, supporting planned and ongoing drug marketing applications across RevMed programs. The role partners closely with Global Regulatory Science and Global Filing and Registration and contributes to the broader Global Regulatory Affairs function at RevMed. This position reports to the Senior Director, Global Regulatory Affairs Project Management. The ideal candidate will have an in-depth understanding of oncology drug development and demonstrated hands-on regulatory project management experience supporting early- and late-stage registrational programs, including the execution of global new drug marketing applications, in alignment with corporate objectives. Core Responsibilities: - Project manage regulatory submissions from initiation through submission, supporting the ### Senior Manager, GMP Quality - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-06-03 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7762856003 - Excerpt: Senior Manager, GMP Quality Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Senior Manager, GMP Quality who will play a key role within Quality Assurance and is responsible for providing leadership and operational support for RevMed commercial programs, with a primary focus on commercial finished product batch review, disposition, and release activities in support of global product supply. Responsibilities: - Serve as the QA lead for commercial finished product (FP) batch review and disposition activities, ensuring timely and compliant release of commercial product for distribution. - Perform comprehensive review and approval of executed batch records, deviations, investigations, analytical data, Certificates of Analysis (CoAs), and associated release documentation for commercial product disposition. - Provide QA oversight for commercial manufacturing, packaging, labeling, testing, storage, and release operations performed at CMOs, contract laboratories, and distribution partners. - Collaborate cross-functionally with Pharmaceutical Development & Manufacturing (PDM/CMC), Supply Chain, Regulatory Affairs, Technical Operations, Validation, and ### Pega Administrator - Citigroup Inc. - Location: CHENNAI, Tamil Nādu, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - 401(k) match: listed (not source-backed) - Apply: https://citi.eightfold.ai/careers/job/859034907965 - Excerpt: Pega Administrator CHENNAI, Tamil Nādu, India ### Senior Manager, Marketing, Lung - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $150K-$189K - Posted: 2026-06-09 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7767420003 - Excerpt: Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for ### Director, Biostatistics - Early Phase - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7693896003 - Excerpt: Director, Biostatistics - Early Phase Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle. - Provide statistical support and strategic input to clinical development plans and target product profiles, proof of concept criteria, and team's preparation for company governance reviews. - Represent Biostatistics function on cross-function teams at program level and serve as a lead statistician for oncology studies - Collaborate with various functions on study design and planning, protocol development, statistical analysis plan and analysis specifications. - Provide statistical support for study protocol development, analysis plan and specification through direct involvement and/or providing guidance to junior staff. - Plan and prepare independent data monitoring committee (DMC), coordinate with independent statistical ### Senior Tool admin (Polarion/Jama) - Renesas Electronics - Location: Ho Chi Minh, , Vietnam (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - 401(k) match: listed (not source-backed) - Apply: https://jobs.smartrecruiters.com/RenesasElectronics/744000131648024-senior-tool-admin-polarion-jama- - Excerpt: Senior Tool admin (Polarion/Jama) Ho Chi Minh, , Vietnam Company Description: Job Description: Job Purpose & Dimensions Given the organic growth of our enterprise, we do have the need to establish a central pool of tools, with a standardized way of using them in development, in order to assure development excellence, a high standard of quality and reuse across our SW assets, and investment efficiency in SW Tools, particularly in the area of open-source code security vulnerabilities, and code-quality risks derived from it. Work closely with SW development teams who are using Polarion, 3DS, R4J and Jama tools, and manage the tool to be used in a managed fashion in order to provide business added value. Principal Accountabilities Maintain the requirements management tools in use (Polarion, 3DS, Jama, R4J) or other requirements management system on the existing infrastructure. Understand business requirements for the usage of the requirements management tools in use, and be the referee regarding which tool fits better each use-case. Design and develop custom-made solutions for traceability, implementation & test status reports in the requirements management tools in use, with respect to the business requirements from this category of tools. Proactively advice & support the Renesas Engineers with usage of the requirements management tools and provide coaching regarding the best practices for requirements management. Coach the reports creation and usage of the tools according best practices, tool performance and aSPICE compliance. Offer online training for Engineering staff regarding the configuration & usage of the tools in target. Understand ### Senior Account Executive - KSA - Cohere Health - Location: Riyadh | OnSite (onsite) - Salary: Not disclosed - Posted: 2026-06-10 - Non-birth-parent leave: 6 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://jobs.ashbyhq.com/cohere/c199be74-1770-4db2-a06e-474bad4716fe - Excerpt: Senior Account Executive - KSA Riyadh | OnSite Who are we? Our mission is to scale intelligence to serve humanity. We're training and deploying frontier models for developers and enterprises who are building AI systems to power magical experiences like content generation, semantic search, RAG, and agents. We believe that our work is instrumental to the widespread adoption of AI. We obsess over what we build. Each one of us is responsible for contributing to increasing the capabilities of our models and the value they drive for our customers. We like to work hard and move fast to do what's best for our customers. Cohere is a team of researchers, engineers, designers, and more, who are passionate about their craft. Each person is one of the best in the world at what they do. We believe that a diverse range of perspectives is a requirement for building great products. Join us on our mission and shape the future! WHY THIS ROLE? In this role, you will own the full sales cycle for strategic enterprise and public-sector organizations across the Kingdom of Saudi Arabia. Your portfolio will include major sectors such as financial services, telecommunications, government, energy, healthcare, and large national enterprises. We are seeking a consultative, strategic seller who excels at building long-term partnerships and navigating complex, high-stakes enterprise and government environments. You will lay the foundation for Cohere's growth in the Kingdom by owning your territory and collaborating closely with Customer Success, Sales Development, Marketing, and Sales Engineering. This ### Senior Director, Responsible Pharmacist (Pharmacien Responsable), France - Revolution Medicines - Location: Remote (France) (remote) - Salary: Not disclosed - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7694372003 - Excerpt: Senior Director, Responsible Pharmacist (Pharmacien Responsable), France Remote (France) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: General Purpose The Senior Director, Head Pharmacist/Responsible Pharmacist guarantees the pharmaceutical responsibility of the laboratory as “exploitant” (see definition of the “exploitant”, Article R.5124-2, 3 ° of the French Public Health Code) and assumes the role of "Responsible Pharmacist" as described in Article R.5124-36 of the Public Health Code. Responsibilities include: - Organize and supervise all pharmaceutical operations of the company or organization, including manufacturing, advertising, information, pharmacovigilance, batch monitoring and withdrawal, distribution, import and export of the drugs, products, objects or articles concerned, as well as the corresponding storage operations. - Ensure that transport conditions guarantee the proper preservation, integrity and safety of these medicines, products, objects or articles. - Acknowledge the files related to marketing authorization applications submitted by Corporate or organization and any other application related to the activities they organize and supervise. - Participate in the development of research ### Vice President, Analytical Development & Quality Control - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $294K-$367K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695261003 - Excerpt: Vice President, Analytical Development & Quality Control Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a strategic and execution-driven Vice President, Analytical Development & Quality Control (ADQC) to lead the vision, strategy, and execution of analytical development and QC across our growing portfolio. Reporting to the Senior Vice President, Pharmaceutical Development & Manufacturing, this executive will build and scale a phase-appropriate, forward-looking analytical organization that enables rapid development of small molecule programs while positioning the company for late-stage development and global commercialization. As a key member of the PDM leadership team, this role will shape analytical strategy at the enterprise level, ensuring robust control strategies, regulatory readiness, and operational excellence across internal and external networks. Responsibilities: Strategic & Organizational Leadership - Define and drive the enterprise-wide analytical development and QC strategy aligned with portfolio and corporate objectives. - Build, lead, and scale a high-performing ADQC organization to support a multi-asset oncology pipeline. ### ASS Purwakarta - Mondelez International - Location: Indonesia (Remote) (remote) - Salary: Not disclosed - Posted: 2026-05-18 - 401(k) match: listed (not source-backed) - Apply: https://mdlz.wd3.myworkdayjobs.com/External/job/Indonesia-Remote/ASS-Purwakarta_R-167210 - Excerpt: ASS Purwakarta Indonesia (Remote) posted: Posted 25 Days Ago ### Director, Clinical Pharmacology - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-05-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7747200003 - Excerpt: Director, Clinical Pharmacology Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and energetic individual with a relevant scientific background to be part of the Nonclinical Development and Clinical Pharmacology (NDCP) Organization. As a key member of the Clinical Pharmacology group, you will: - Represent the clinical pharmacology function in project teams and build strong working relationships with cross-functional teams to impact critical decisions. - Responsible for clinical pipeline delivery through major milestones including IND/CTA, EOP2, and marketing applications NDA/sNDA. - Lead the design and execution of an integrated clinical pharmacology and modeling and simulation strategy to guide the clinical development plan. - Apply state-of-the-art quantitative pharmacology analyses, including population PK, exposure-response analyses, to guide dose/schedule selection and recommended phase 2 dose and schedule (RP2Ds) selection. - Author and provide technical input for regulatory documents and submissions related to all aspects of clinical pharmacology (including protocol, CSR, IB, briefing package, --- Source-backed benefit claims include source links; other benefit values are labeled separately.